This research study is a Phase II clinical trial, which tests the safety and effectiveness of
an investigational drug to learn whether the drug works in treating a specific cancer.
"Investigational" means that the study drug tivozanib is still being studied. It also means
that the FDA has not yet approved tivozanib for your type of cancer.
Tivozanib is an anti-angiogenesis medicine that fights different types of cancer by blocking
the blood supply to the tumor, so that the tumor does not receive the nutrients it requires
to grow.
In this research study, we are looking to see what effects, good and bad, tivozanib will have
on you and your disease.